Role of diaphragmatic surgery in 69 patients with ovarian carcinoma

International Journal of Gynecological Cancer

Volumn 18, Issue 2, 2008, Pages 363-368

  Devolder, K ^a   Amant, F ^a   Neven, P ^a   Van Gorp, T ^a   Leunen, K ^a   Vergote, I ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Complications; Debulking surgery; Diaphragm stripping; Diaphragmatic tumor; Ovarian cancer; Relapse; Survival

Indexed keywords

ARTICLE; ATELECTASIS; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIAPHRAGM DISEASE; DIAPHRAGM STRIPPING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LASER COAGULATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELAPSE; SURGICAL TECHNIQUE; THORAX DRAINAGE;

ADENOCARCINOMA; DIAPHRAGM; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; MUSCLE NEOPLASMS; OVARIAN NEOPLASMS;

EID: 40549092704     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01006.x     Document Type: Article

References (25)

1. Tan DS, Argarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol 2006 7 : 925 34.
2. Griffiths CT, Fuller AF. Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surg Clin North Am 1978 58 : 131 42.
3. Redman JR, Petroni GR, Saigo PE, Geller NL, Hakes TB. Prognostic factors in advanced ovarian carcinoma. J Clin Oncol 1986 4 : 515 23.
4. Heintz AP, Van Oosterom AT, Trimbos JB, Schaberg A, Van Der Velde EA, Nooy M. The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis. Gynecol Oncol 1988 30 : 347 58.
5. Voest EE, Van Houwelingen JC, Neijt JP. A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival as main objectives. Eur J Cancer Clin Oncol 1989 25 : 711 20.
6. Neijt JP, Ten Bokkel Huinink WW, Van Der Burg ME et al. Long-term survival in ovarian cancer. Eur J Cancer 1991 27 : 1367 72.
7. Potter ME, Partridge EE, Hatch KD, Soong S, Austin JM, Shingleton HM. Primary surgical therapy of ovarian cancer: how much and when. Gynecol Oncol 1991 40 : 195 200.
8. Hunter WR, Alexander ND, Soutter WP. Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 1992 166 : 504 11.
9. Hoskins WJ, Bundy BN, Thigpen JT, Omura GA. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynaecologic Oncology Group study. Gynecol Oncol 1992 47 : 159 66.
10. Eisenkop SM, Nalick RH, Wang H, Teng NN. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol 1993 51 : 224 9.
11. Högberg T, Carstensen J, Simonsen E. Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer. Gynecol Oncol 1993 48 : 38 49.
12. Hoskins WJ, McGuire WP, Brady MF et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994 170 : 974 80.
13. Nunns D, Symonds P, Ireland D. Surgical management of advanced ovarian cancer. Obstet Gynecol Surv 2000 50 : 746 51.
14. Pecorelli S, Odicino F, Favalli G. Ovarian cancer: best timing and applications of debulking surgery. Ann Oncol 2000 11 (Suppl. 3 141 3.
15. Ng LW, Rubin SC, Hoskins WJ et al. Aggressive chemosurgical debulking in patients with advanced ovarian cancer. Gynecol Oncol 1990 38 : 358 63.
16. Vergote IB, De Wever I, Decloedt J, Tjalma W, Van Gramberen M, Van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 1998 71 : 431 6.
17. Vergote IB, De Wever I, Decloedt J, Tjalma W, Van Gramberen M, Van Dam P. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer. Semin Oncol 2000 27 : 31 6.
18. Vergote I, Marquette S, Amant F, Berteloot P, Neven P. Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer 2005 15 : 776 9.
19. Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 1999 72 : 278 87.
20. Montz FJ, Schlaerth JB, Berek JS. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol 1989 35 : 338 40.
21. Cliby W, Dowdy S, Feitoza SS, Gostout BS, Podratz KC. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol 2004 94 : 655 60.
22. Chi DS, Franklin CC, Levine DA et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 2004 94 : 650 4.
23. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol 2006 100 : 283 7.
24. Juretzka MM, Horton FR, Abu-Rustum NR et al. Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature. Gynecol Oncol 2006 100 : 618 20.
25. Aletti GD, Dowdy SC, Gostout BS et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 2006 107 : 77 85.